Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Payne

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
BJU International|June 29, 2023
External validation of a risk model predicting failure of salvage focal ablation for prostate cancerAlexander Light, Max Peters, Deepika Reddy, et al.
European Urology|January 21, 2023
Corrigendum to "Magnetic Resonance Imaging and targeted biopsies compared to transperineal mapping biopsies prior to salvage focal therapy/ablation in localised and metastatic recurrent prostate cancer after radiotherapy. Primary Outcomes from the FORECAST Trial" [Eur Urol 2022;81(6):598-605]Taimur T Shah, Abi Kanthabalan, Marjorie Otieno, et al.
European Urology|July 2, 2015
Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified ApproachAlicia K Morgans, Annelotte C M van Bommel, Caleb Stowell, et al.
Lancet (London, England)|May 19, 2024
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trialChris C Parker, Howard Kynaston, Adrian D Cook, et al.
Lancet (London, England)|May 19, 2024
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trialChris C Parker, Noel W Clarke, Adrian D Cook, et al.
Lancet (London, England)|October 1, 2020
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trialChristopher C Parker, Noel W Clarke, Adrian D Cook, et al.
Science Translational Medicine|November 2, 2022
An immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expressionEddie Cano-Gamez, Katie L Burnham, Cyndi Goh, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
BJU International|June 29, 2023
External validation of a risk model predicting failure of salvage focal ablation for prostate cancerAlexander Light, Max Peters, Deepika Reddy, et al.
European Urology|January 21, 2023
Corrigendum to "Magnetic Resonance Imaging and targeted biopsies compared to transperineal mapping biopsies prior to salvage focal therapy/ablation in localised and metastatic recurrent prostate cancer after radiotherapy. Primary Outcomes from the FORECAST Trial" [Eur Urol 2022;81(6):598-605]Taimur T Shah, Abi Kanthabalan, Marjorie Otieno, et al.
European Urology|July 2, 2015
Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified ApproachAlicia K Morgans, Annelotte C M van Bommel, Caleb Stowell, et al.
Lancet (London, England)|May 19, 2024
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trialChris C Parker, Howard Kynaston, Adrian D Cook, et al.
Lancet (London, England)|May 19, 2024
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trialChris C Parker, Noel W Clarke, Adrian D Cook, et al.
Lancet (London, England)|October 1, 2020
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trialChristopher C Parker, Noel W Clarke, Adrian D Cook, et al.
Science Translational Medicine|November 2, 2022
An immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expressionEddie Cano-Gamez, Katie L Burnham, Cyndi Goh, et al.
Pageof 12